Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease-Reference-Cited by-同舟云学术

Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease

Published:1999-05-01 Issue:10 Volume:42 Page:1855-1861
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yu Qian-sheng¹,Holloway Harold W.¹,Utsuki Tadanobu¹,Brossi Arnold¹,Greig Nigel H.¹

Affiliation:

1. Drug Design & Development, Laboratory of Cellular and Molecular Biology, Gerontology Research Center (4E02), National Institute on Aging Intramural Research Program, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, Maryland 21224-6825, and School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina 27599-7361

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980459s

Reference29 articles.

1. Diagnosis of Alzheimer's Disease

2. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

3. Alzheimer Disease

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review on the Genus Haloxylon: Pharmacological and Phytochemical Properties;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08

2. Synthesis and molecular docking study of thiophene-bearing thiourea derivatives as potential acetylcholinesterase, and butyrylcholinesterase inhibitors;Chemical Data Collections;2024-03

3. Nitrite-catalyzed economic and sustainable bromocyclization of tryptamines/ tryptophols to access hexahydropyrrolo[2,3-b]indoles/tetrahydrofuroindolines in batch and flow;Chinese Chemical Letters;2023-11

4. Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies;European Journal of Medicinal Chemistry;2023-03

5. Pseudo-irreversible butyrylcholinesterase inhibitors: Structure–activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead;European Journal of Medicinal Chemistry;2023-02